Start-up Orixha, a spin-off from Erganeo specialising in fluid ventilation technology, has raised €4 million from the European Innovation Council Fund (EIC) and the French Tech Seed fund managed by Bpifrance.
The technology developed by the start-up enables ventilation with an oxygenated breathing liquid. The first clinical application of the Vent2Cool device is aimed at improving the care of post-cardiac arrest resuscitation patients.
Orixha is supported by the EIC Fund and Bpifrance in its efforts to become a world leader in this field. This technology opens up new perspectives in intensive care, offering innovative treatment possibilities for critical patients.
Erganeo is delighted by this fundraising, ensuring the continuation of the development of the medical device Vent2Cool.